yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
Red Hat
The Opening of Virtualization
User Environment Management – The Third Layer of the Desktop
Cloud Computing for Business Agility
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Return on Assests: Bringing Visibility to your SOA Strategy
Managing Hybrid Endpoint Environments
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
How Can AJAX Improve Homeland Security?
Beyond Widgets: What a RIA Platform Should Offer
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Today's Top SOA Links

ALR Technologies Letter to Shareholders

RICHMOND, VA -- (Marketwire) -- 02/04/13 -- ALR Technologies (OTCBB: ALRT), a medical device company providing remote monitoring and care facilitation for patients with chronic diseases, today delivered the following letter to its shareholders.

February 4, 2013

Dear Shareholders:

I wanted to take a moment to update you on the recent progress of ALR Technologies and to lay out our strategy for the commercialization of our services and our technology.

After we received FDA clearance, we achieved HIPAA compliance for our Health-e-Connect system in the fall of 2012. With these key milestones and a successful clinical trial under our belt, we began to implement our commercialization strategy.

That strategy is built upon three emerging trends in the healthcare marketplace:

1. Diabetes prevalence is exploding in the United States and worldwide. Technologies and services that can assist patients, providers, caregivers and healthcare payers in grappling with diabetes care will be in high demand.

2. The patient load of primary care physicians in the United States will increase dramatically and these physicians will require support from new technologies as well as assistance from care managers, family members and others in order to provide quality care. On January 29th, a U.S. Senate subcommittee held a hearing on what the Chairman described as a "major crisis" in primary healthcare as 30 million new patients will have access to care under the Affordable Care Act. A new primary care model will emerge which will take advantage of new technologies. The Annals of Family Medicine recently carried an article on this new trend in primary care medicine: (

3. Healthcare payers in the United States and worldwide are actively seeking technologies and services to improve quality and lower the costs of managing chronic diseases. In the highly competitive U.S. market, major healthcare plans have shown particularly strong interest in remote monitoring platforms that can accomplish these quality and cost goals.

Therefore, our commercialization strategy is designed to capitalize on these important market trends and to provide a technology and service that will improve the quality of care and lower the costs of care for diabetes patients. We believe that, given the trends described above, our product will be in high demand in the coming years.

Our primary, and most important, goal is to begin securing revenue-generating customers in the commercial marketplace. We have done three things to push us toward this goal. First, we added several members to our sales and marketing team, as well as highly experienced professionals who understand the care needs of diabetes patients to focus on our key customer segments, such as health plans. Second, we have developed pricing models for the various customer segments, including risk sharing pricing arrangements for health plans that minimize the up front financial risk for the customer, yet rewards ALRT for delivering improved quality and lower costs. Finally, we have ramped up our sales efforts and we have been aggressively meeting with key customer targets on a regular basis.

Finally, I want to thank the shareholders who have expressed confidence in the future success of ALRT. I want to remind all investors that we are not selling a "widget" or an "app"; we are selling a comprehensive remote monitoring and care facilitation system that will be used by patients with a very serious condition. Therefore, our technology will only be purchased after careful consideration of the quality of the technology and the services we provide. In short, our customers will make their decisions neither lightly nor quickly. At ALRT, we continue to believe that if we pay great attention to quality, in both our product and our staff, our product will be widely adopted and we will achieve considerable success in the marketplace.

Yours truly,

Sidney S Chan
Chairman & Chief Executive Officer

About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange

Bill Smith:

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
This is how a typical software product lifecycle works : You gather requirements, build a prototype, detail out the architecture and design, develop the product, test it, deploy the product, handle migration and maintenance and ensure product support. This is a closed loop where the Pr...
Intuit uses deep-data analytics to gain a 360-degree view of its TurboTax application's users’ behavior and preferences for rapid applications improvements. The next BriefingsDirect big-data innovation case study highlights how Intuit uses deep-data analytics to gain a 360-degree view...
Certain CIOs for incomprehensible reasons keep off their cloud transformation projects several key IT disciplines including Enterprise Architecture (EA), IT Service Management (ITSM) and most importantly Project Management. Do they consider them obsolete? useless? irrelevant? ITaaS St...
In today’s pharmaceutical supply chain, counterfeit activity is thriving. As pharma companies have expanded target markets and outsourced production over the last decade, the supply chain has become increasingly global, virtual, and vulnerable. Illicit activity has thrived, and patient...
Here’s the thing: as sure as we’ll have another record-setting year for NFL streaming, you can also be sure that apps will fail and streaming services will go down. Whether you are dabbling in streaming or diving in whole-hog, you need to know what to do to give your users the most rel...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers